Beyond the SSRIs
Journal of the Korean Society of Biological Psychiatry
;
: 34-40, 1999.
Artigo
em Coreano
| WPRIM
| ID: wpr-724888
ABSTRACT
New antidepressants have become available for clinical use in the 1990s. Before this decade, the drugs available to treat depression consisted essentially of monoamine oxidase inhibitors, tricyclic antidepressants, and lithium. Following the introduction of SSRIs, the options have expanded and now include SSRIs nefazodone, venlafaxine, mirtazapine, reboxetine, tianeptine. Newer antidepressants possess a variety of pharmacological characteristics that are relevant to the choice of an antidepressant for clinical use. This review summarizes some of the major pharmacological characteristics among the drugs.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Depressão
/
Cloridrato de Venlafaxina
/
Lítio
/
Inibidores da Monoaminoxidase
/
Antidepressivos
/
Antidepressivos Tricíclicos
Idioma:
Coreano
Revista:
Journal of the Korean Society of Biological Psychiatry
Ano de publicação:
1999
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS